Beleh M A, Lin Y C, Brueggemeier R W
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University, Columbus 43210, USA.
J Steroid Biochem Mol Biol. 1995 May;52(5):479-89. doi: 10.1016/0960-0760(95)00003-i.
The estrogen-treated golden Syrian hamster has been used as an experimental model for estrogen-induced and estrogen-dependent cancers, but pathways to neoplastic transformation remain unknown in this animal. Metabolism of estrogens to activated or reactive compounds, followed by subsequent oxidative damage to the target tissue, remains a potential step in the tumorigenic process. In this study, the extent of estrogen metabolism is compared in three different in vitro preparations from untreated and estrogen-treated Syrian hamsters, primary kidney cell cultures, microsomal preparations, and freshly prepared tissue kidney slices. In primary kidney cell cultures, the amount of catechol estrogens decreased upon increasing estrogen (DES) treatment period, and completely disappeared after about 6 months treatment. This decrease is not a result of formation of less amounts of catechol estrogens, but rather reflects the presence of the enzyme systems to further metabolize any formed catechol estrogens, since the amount of catechol estrogens formed, as detected by 3H2O release, is unchanged. The polar metabolites a, b and c increased with estrogen treatment, and metabolite c appeared only after DES treatment. The appearance of polar metabolite c only in kidney preparations from DES-treated animals implies that it may serve as a marker of cellular transformation. Estriol and estrone were detected, but were not affected by DES treatment, while no methoxyestrogens were isolated. Studies of estradiol metabolism in microsomal preparations showed a very low rate of metabolism, compared to the primary kidney cell cultures. In contrast, estrogen metabolism was extensive in kidney slices from untreated hamsters, with only approx. 30% of the substrate estradiol remaining unmetabolized after 6 h of incubation. While no catechol estrogens were detected, a small quantity of estriol, and a large amount of estrone and methoxyestrogens were isolated. The polar metabolite a was the main polar metabolite detected, with very little of metabolite b and no metabolite c. In kidney slices from 4 month DES-treated hamsters, a much higher amount of polar metabolites was detected, and metabolite c appeared after 6 h incubation. Mass spectrometric analysis and HPLC data of metabolite c indicate that this metabolite is 15 alpha-hydroxyesteradiol. This metabolite may serve as a biomarker for changes occurring in the hamster kidney cells under continuous estrogen exposure. Finally, formation of water soluble conjugates was demonstrated in both kidney slices and liver slices from Syrian hamsters, with glucuronide, sulfate and thioether conjugates of estrone and estradiol and glucuronides of catechol estrogens detected.(ABSTRACT TRUNCATED AT 400 WORDS)
雌激素处理过的金黄叙利亚仓鼠已被用作雌激素诱导和雌激素依赖性癌症的实验模型,但在这种动物中肿瘤转化的途径仍不清楚。雌激素代谢为活化或反应性化合物,随后对靶组织造成氧化损伤,仍然是致癌过程中的一个潜在步骤。在本研究中,比较了来自未处理和雌激素处理的叙利亚仓鼠的三种不同体外制剂(原代肾细胞培养物、微粒体制剂和新鲜制备的肾组织切片)中雌激素的代谢程度。在原代肾细胞培养物中,随着雌激素(己烯雌酚)处理时间的增加,儿茶酚雌激素的量减少,在处理约6个月后完全消失。这种减少不是形成较少儿茶酚雌激素的结果,而是反映了存在进一步代谢任何形成的儿茶酚雌激素的酶系统,因为通过3H2O释放检测到的形成的儿茶酚雌激素的量没有变化。极性代谢物a、b和c随着雌激素处理而增加,代谢物c仅在己烯雌酚处理后出现。极性代谢物c仅在己烯雌酚处理动物的肾制剂中出现,这意味着它可能作为细胞转化的标志物。检测到了雌三醇和雌酮,但它们不受己烯雌酚处理的影响,同时未分离出甲氧基雌激素。与原代肾细胞培养物相比,微粒体制剂中雌二醇代谢率非常低。相反,未处理仓鼠的肾切片中雌激素代谢广泛,孵育6小时后仅约30%的底物雌二醇未代谢。虽然未检测到儿茶酚雌激素,但分离出少量雌三醇以及大量雌酮和甲氧基雌激素。极性代谢物a是检测到的主要极性代谢物,代谢物b很少,没有代谢物c。在己烯雌酚处理4个月的仓鼠的肾切片中,检测到的极性代谢物量要高得多,孵育6小时后出现代谢物c。代谢物c的质谱分析和高效液相色谱数据表明该代谢物是15α-羟基雌二醇。这种代谢物可能作为持续雌激素暴露下仓鼠肾细胞中发生变化的生物标志物。最后,在叙利亚仓鼠的肾切片和肝切片中均证实了水溶性结合物的形成,检测到了雌酮和雌二醇的葡萄糖醛酸、硫酸盐和硫醚结合物以及儿茶酚雌激素的葡萄糖醛酸结合物。(摘要截断于400字)